SAN DIEGO--(BUSINESS WIRE)-- Janux Therapeutics, Inc. (Nasdaq ... today announced the promotion of Dr. Zachariah McIver to Chief Medical Officer. “The appointment of Zach to CMO is an important ...

Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Jan. 21, 2025 /PRNewswire/ -- Kyverna Therapeutics, Inc. (Kyverna ... M.D., MBA, to Chief Medical and Development Officer, where he will lead the Company's research, clinical development, and ...

We offer a range of highly regarded undergraduate, postgraduate, research, and short courses in biosciences, health sciences, medicine, psychology, and veterinary medicine. Our mission is to ...

Sage Therapeutics stock opened at $7.44 on Friday. The business’s 50-day simple moving average is $5.64 and its 200 day simple moving average is $7.53. The stock has a market cap of $455.13 ...

Pheno Therapeutics Limited ... is targeted toward treatment of neurological diseases with high unmet medical need, with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs ...

You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> Sage Therapeutics belongs to the Zacks Medical - Biomedical and Genetics industry. Another stock from the same ...